Mentioned On
Episode Mentions
Motley Fool Money · Apr 12, 2026
The Psychedelic Revolution
“Psychedelic biotech company acquired by AbbVie for development of aladicicin compound”
Psychedelic-Assisted Therapy Clinical EfficacyTreatment-Resistant Depression Market OpportunityFDA Approval Pathways for Psychedelic Compounds
View Analysis